Загрузка...
Agonistic CD40 Antibodies in Cancer Treatment
SIMPLE SUMMARY: CD40 is a costimulatory molecule that is key for the activation of antigen-presenting cells and other innate immune cells. It plays an important role in anti-tumor immunity, and agonists of CD40 have been shown to eliminate tumors in both pre-clinical and clinical settings, alone and...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8000216/ https://ncbi.nlm.nih.gov/pubmed/33804039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061302 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|